MARSEILLE, France I3, 2024 I Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the U.S Food ...

India is highly affected by sleep deprivation, with 93% of its population struggling to get adequate rest. Acid reflux or ...

A mother-of-three who “chickened out” of gastric band surgery due to potential complications has instead lost seven stone in ...

The researchers concluded that oART, with BH technique, shows promise in reducing PTV margins and OAR doses in gastric ...

Experts indicate that this rare disorder can lead to various uncomfortable symptoms, including nausea, vomiting, bloating, ...

Unfortunately, too many insurers — including Medicare — still see obesity as a cosmetic issue instead of the disease that it ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

The FDA issues a complete response letter to Vanda's new drug application for tradipitant for treating symptoms in gastroparesis.

The following is a summary of "Preoperative Chemoradiotherapy for Resectable Gastric Cancer," published in the September 2024 ...

Mum Claudette Hawk lost a whopping 11st thanks to surgery but sadly says she can't even look at herself in the mirror due to ...

The US FDA has declined to approve the NDA submitted by Vanda Pharmaceuticals for tradipitant to treat gastroparesis symptoms ...

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with ...